167 related articles for article (PubMed ID: 27128689)
21. Reversal of DNA damage induced Topoisomerase 2 DNA-protein crosslinks by Tdp2.
Schellenberg MJ; Perera L; Strom CN; Waters CA; Monian B; Appel CD; Vilas CK; Williams JG; Ramsden DA; Williams RS
Nucleic Acids Res; 2016 May; 44(8):3829-44. PubMed ID: 27060144
[TBL] [Abstract][Full Text] [Related]
22. An internal ribosome entry site in the coding region of tyrosyl-DNA phosphodiesterase 2 drives alternative translation start.
Chou AC; Aslanian A; Sun H; Hunter T
J Biol Chem; 2019 Feb; 294(8):2665-2677. PubMed ID: 30593505
[TBL] [Abstract][Full Text] [Related]
23. Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential.
Laev SS; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem; 2016 Nov; 24(21):5017-5027. PubMed ID: 27687971
[TBL] [Abstract][Full Text] [Related]
24. Repair of trapped topoisomerase II covalent cleavage complexes: Novel proteasome-independent mechanisms.
Tsuda M; Kitamasu K; Hosokawa S; Nakano T; Ide H
Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):170-184. PubMed ID: 31608820
[TBL] [Abstract][Full Text] [Related]
25. Isoquinoline-1,3-diones as Selective Inhibitors of Tyrosyl DNA Phosphodiesterase II (TDP2).
Kankanala J; Marchand C; Abdelmalak M; Aihara H; Pommier Y; Wang Z
J Med Chem; 2016 Mar; 59(6):2734-46. PubMed ID: 26910725
[TBL] [Abstract][Full Text] [Related]
26. [Tyrosyl-DNA phosphodiesterases: potential targets for cancer treatment].
Hu Z; Wang HW; An LK
Yao Xue Xue Bao; 2016 Feb; 51(2):215-25. PubMed ID: 29856574
[TBL] [Abstract][Full Text] [Related]
27. Structural basis for recognition of 5'-phosphotyrosine adducts by Tdp2.
Shi K; Kurahashi K; Gao R; Tsutakawa SE; Tainer JA; Pommier Y; Aihara H
Nat Struct Mol Biol; 2012 Dec; 19(12):1372-7. PubMed ID: 23104058
[TBL] [Abstract][Full Text] [Related]
28. Cancer sensitizing effect of deazaflavin analogs is associated with increased intracellular drug accumulation.
Belhadj Z; Offei S; Jacobson BA; Cambron D; Kratzke RA; Wang Z; Xie J
Eur J Pharm Sci; 2024 Feb; 193():106686. PubMed ID: 38159687
[TBL] [Abstract][Full Text] [Related]
29. VPg unlinkase/TDP2 in cardiovirus infected cells: Re-localization and proteolytic cleavage.
Maciejewski S; Ullmer W; Semler BL
Virology; 2018 Mar; 516():139-146. PubMed ID: 29353210
[TBL] [Abstract][Full Text] [Related]
30. Development of a novel assay for human tyrosyl DNA phosphodiesterase 2.
Adhikari S; Karmahapatra SK; Elias H; Dhopeshwarkar P; Williams RS; Byers S; Uren A; Roy R
Anal Biochem; 2011 Sep; 416(1):112-6. PubMed ID: 21620793
[TBL] [Abstract][Full Text] [Related]
31. TDP2/TTRAP is the major 5'-tyrosyl DNA phosphodiesterase activity in vertebrate cells and is critical for cellular resistance to topoisomerase II-induced DNA damage.
Zeng Z; Cortés-Ledesma F; El Khamisy SF; Caldecott KW
J Biol Chem; 2011 Jan; 286(1):403-9. PubMed ID: 21030584
[TBL] [Abstract][Full Text] [Related]
32. An RNA virus hijacks an incognito function of a DNA repair enzyme.
Virgen-Slane R; Rozovics JM; Fitzgerald KD; Ngo T; Chou W; van der Heden van Noort GJ; Filippov DV; Gershon PD; Semler BL
Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14634-9. PubMed ID: 22908287
[TBL] [Abstract][Full Text] [Related]
33. Usnic Acid Derivatives Inhibit DNA Repair Enzymes Tyrosyl-DNA Phosphodiesterases 1 and 2 and Act as Potential Anticancer Agents.
Zakharenko AL; Dyrkheeva NS; Luzina OA; Filimonov AS; Mozhaitsev ES; Malakhova AA; Medvedev SP; Zakian SM; Salakhutdinov NF; Lavrik OI
Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895279
[TBL] [Abstract][Full Text] [Related]
34. New Dual Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 and 2 Based on Deoxycholic Acid: Design, Synthesis, Cytotoxicity, and Molecular Modeling.
Salomatina OV; Kornienko TE; Zakharenko AL; Komarova NI; Achara C; Reynisson J; Salakhutdinov NF; Lavrik OI; Volcho KP
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338326
[TBL] [Abstract][Full Text] [Related]
35. Triazolopyrimidine and triazolopyridine scaffolds as TDP2 inhibitors.
Ribeiro CJA; Kankanala J; Xie J; Williams J; Aihara H; Wang Z
Bioorg Med Chem Lett; 2019 Jan; 29(2):257-261. PubMed ID: 30522956
[TBL] [Abstract][Full Text] [Related]
36. Tyrosyl-DNA phosphodiesterases: rescuing the genome from the risks of relaxation.
Kawale AS; Povirk LF
Nucleic Acids Res; 2018 Jan; 46(2):520-537. PubMed ID: 29216365
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl-DNA Phosphodiesterase 2 (Tdp2).
Wang P; Elsayed MSA; Plescia CB; Ravji A; Redon CE; Kiselev E; Marchand C; Zeleznik O; Agama K; Pommier Y; Cushman M
J Med Chem; 2017 Apr; 60(8):3275-3288. PubMed ID: 28418653
[TBL] [Abstract][Full Text] [Related]
38. Effect of TDP2 on the Level of TOP2-DNA Complexes and SUMOylated TOP2-DNA Complexes.
Lee KC; Swan RL; Sondka Z; Padget K; Cowell IG; Austin CA
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011940
[TBL] [Abstract][Full Text] [Related]
39. ERK3 regulates TDP2-mediated DNA damage response and chemoresistance in lung cancer cells.
Bian K; Muppani NR; Elkhadragy L; Wang W; Zhang C; Chen T; Jung S; Seternes OM; Long W
Oncotarget; 2016 Feb; 7(6):6665-75. PubMed ID: 26701725
[TBL] [Abstract][Full Text] [Related]
40. Toxoflavins and deazaflavins as the first reported selective small molecule inhibitors of tyrosyl-DNA phosphodiesterase II.
Raoof A; Depledge P; Hamilton NM; Hamilton NS; Hitchin JR; Hopkins GV; Jordan AM; Maguire LA; McGonagle AE; Mould DP; Rushbrooke M; Small HF; Smith KM; Thomson GJ; Turlais F; Waddell ID; Waszkowycz B; Watson AJ; Ogilvie DJ
J Med Chem; 2013 Aug; 56(16):6352-70. PubMed ID: 23859074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]